Table 2 Household and individual characteristics of the 2017 epilepsy survey (Kitgum, Pader and Moyo districts)

 Number of households: n (%)

142 (36.4)

55 (14.1)

197 (50.5)

193 (49.5)

 Median household size: n (IQR)

6 (4–8)

6 (4–8)

6 (4–8)

5 (3–7)

 Agriculture as main activity: n (%)

134 (94.4)

54 (98.2)

188 (98.9)

184 (95.3)

 Family history of death from epilepsy: n (%)

15 (10.6)

2 (3.36)

17 (8.6)

7 (3.6)

 Age (years) at death of PWE^a: median (IQR)

16 (13–19)

33 (22–44)

16 (13–19)

17 (14–28)

 Number of participants: n (%)

861 (40.2)

316 (14.8)

1177 (55.1)

961 (45.0)

 Age: median (IQR)

16 (8–29)

17 (7–26)

16 (7–28)

16 (8–30)

 Male gender: n (%)

419 (50.5)

163 (53.4)

582 (51.3)

442 (48.2)

 Ivermectin use in 2017: n (%)

716 (83.5)

249 (79.6)

965 (82.5)

779 (81.2)

 0–9

258 (29.8)

98 (31.0)

356 (30.3)

279 (29.0)

 10–19

260 (30.2)

89 (28.2)

349 (29.7)

268 (27.9)

 20–29

131 (15.2)

61 (19.3)

192 (16.3)

154 (16.0)

 30–39

77 (8.9)

20 (6.3)

97 (8.2)

93 (9.7)

  ≥ 40

135 (15.7)

48 (15.2)

183 (15.6)

167 (17.9)

 Number of PWE^a:

83

29

112

46

 Male gender: n (%)

49 (59.0)

17 (58.6)

66 (58.9)

21 (45.7)

 Female gender: n (%)

34 (41.0)

12 (41.4)

46 (41.1)

25 (54.3)

 Age in years: median (IQR)

19 (16–22)

16 (14–18)

18 (16–20)

23 (15–36)

 Age at seizure onset (years): median (IQR)^b

9 (7–12)

8 (7–11)

9 (7–12)

10 (2–15)

 Year of onset of seizures: median (IQR)^b

2007 (2005–2010)

2010 (2009–2012)

2008 (2006–2011)

2009 (2000–2012)

 Positive Ov16 test: n (%)^c

13 (27.7)

8 (50.0)

21 (33.3)

16 (36.4)